Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Petrobras Class A
PBR.A
$104B
| $4.51M | ﹤0.01% |
317,486
+151,713
| +92% | +$2.09M |
|
|
AIFU
3077
AIFU Inc
AIFU
$215M
| $4.51M | ﹤0.01% |
337
+316
| +1,505% | +$3.6M |
|
3078
CALL
Invesco
IVZ
$14.4B
| $4.51M | ﹤0.01% |
220,300
-143,800
| -39% | -$2.99M |
|
3079
AAR Corp
AIR
$5.85B
| $4.51M | ﹤0.01% |
122,511
-196,669
| -62% | -$6.51M |
|
|
CBIO
3080
Crescent Biopharma
CBIO
$637M
| $4.5M | ﹤0.01% |
3,780
-3,607
| -49% | -$4.31M |
|
3081
PUT
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.38B
| $4.5M | ﹤0.01% |
31,300
-10,800
| -26% | -$1.54M |
|
3082
CoreCivic
CXW
$3.25B
| $4.5M | ﹤0.01% |
216,601
-107,010
| -33% | -$2.3M |
|
3083
DHT Holdings
DHT
$3.15B
| $4.49M | ﹤0.01% |
759,706
+645,489
| +565% | +$3.52M |
|
|
OXFD
3084
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $4.49M | ﹤0.01% |
326,304
+238,001
| +270% | +$3.64M |
|
3085
CALL
State Street SPDR S&P Dividend ETF
SDY
$22.2B
| $4.49M | ﹤0.01% |
44,500
-4,000
| -8% | -$400K |
|
3086
CALL
Invesco CurrencyShares Canadian Dollar Trust
FXC
$73.9M
| $4.48M | ﹤0.01% |
59,500
+22,000
| +59% | +$1.62M |
|
3087
Anika Therapeutics
ANIK
$288M
| $4.48M | ﹤0.01% |
110,177
-50,082
| -31% | -$1.83M |
|
3088
Community Bank
CBU
$3.46B
| $4.48M | ﹤0.01% |
67,985
+2,334
| +4% | +$150K |
|
3089
Innoviva
INVA
$1.53B
| $4.47M | ﹤0.01% |
306,772
+5,060
| +2% | +$71.7K |
|
3090
PUT
AngloGold Ashanti
AU
$48.7B
| $4.46M | ﹤0.01% |
250,400
-2,000
| -0.8% | -$26.8K |
|
|
IIN
3091
DELISTED
IntriCon Corporation
IIN
| $4.46M | ﹤0.01% |
190,867
-113,696
| -37% | -$2.84M |
|
|
MNRL
3092
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $4.46M | ﹤0.01% |
+207,696
| New | +$4.31M |
|
3093
PUT
Alnylam Pharmaceuticals
ALNY
$30.6B
| $4.46M | ﹤0.01% |
61,400
+3,600
| +6% | +$276K |
|
3094
IPG Photonics
IPGP
$3.65B
| $4.45M | ﹤0.01% |
+28,867
| New | +$4.37M |
|
3095
Supernus Pharmaceuticals
SUPN
$2.81B
| $4.45M | ﹤0.01% |
134,555
-12,083
| -8% | -$414K |
|
3096
PUT
Box
BOX
$4.52B
| $4.45M | ﹤0.01% |
252,700
+81,100
| +47% | +$1.55M |
|
3097
Genesis Energy
GEL
$1.93B
| $4.45M | ﹤0.01% |
203,098
+172,391
| +561% | +$3.84M |
|
3098
iShares S&P 100 ETF
OEF
$20.5B
| $4.45M | ﹤0.01% |
34,321
+18,368
| +115% | +$2.35M |
|
|
CSFL
3099
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $4.45M | ﹤0.01% |
+193,075
| New | +$4.53M |
|
3100
First Financial Bancorp
FFBC
$3.61B
| $4.44M | ﹤0.01% |
183,501
+173,029
| +1,652% | +$4.16M |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.